A Study Comparing the Differences Between Young and Non-young Breast Cancer
NCT06793306 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2025-02-14
Summary
To collect data on diagnosis, treatment, survival prognosis, and intrinsic molecular detection of breast cancer in China from January 2000 to December 2024.Compare the difference between young and non-young breast cancer.
Conditions
Interventions
- OTHER
-
Age
Breast cancer patients were divided into young breast cancer and non-young breast cancer by age 35
- OTHER
-
combination therapy
To observe and compare the difference in diagnosis, combined treatment and prognosis between young and non-young breast cancer
Sponsors & Collaborators
-
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2030-01-31
- Completion
- 2030-01-31
Countries
- China
Study Locations
More Related Trials
-
Predicting Long-Term Clinical Outcomes in Chinese Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT06856616 ·Status: ACTIVE_NOT_RECRUITING
-
A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
NCT06591039 ·Status: RECRUITING
-
Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
NCT04683770 ·Status: UNKNOWN
-
The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer
NCT06718010 ·Status: RECRUITING
-
Familial Breast Cancer in China
NCT06833216 ·Status: NOT_YET_RECRUITING
-
Breast Tissue Study of Breast Diseases Among Women in Hong Kong
NCT01885039 ·Status: COMPLETED
-
Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology
NCT05441098 ·Status: UNKNOWN
-
Patterns of Breast Cancer Management and Prognosis of Breast Cancer in China
NCT04076111 ·Status: NOT_YET_RECRUITING
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China
NCT02493569 ·Status: UNKNOWN
-
Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer Patients
NCT05680194 ·Status: RECRUITING
-
Clinical Study on Triple Negative Breast Cancer With Chinese Medicine
NCT03332368 ·Status: UNKNOWN
-
Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine
NCT06102018 ·Status: RECRUITING
-
Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer
NCT04145960 ·Status: UNKNOWN
-
Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound
NCT06902935 ·Status: NOT_YET_RECRUITING
-
The Study on the Clinical Utility of Liquid Biopsy in Breast Cancer
NCT02902991 ·Status: UNKNOWN
-
Ultrasound-based Breast Cancer Screening in Chinese Women
NCT02268643 ·Status: UNKNOWN
-
Hong Kong Breast Cancer Study
NCT02889458 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
NCT05326295 ·Status: RECRUITING
-
A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases
NCT06544668 ·Status: NOT_YET_RECRUITING
-
An AI Model Predicts the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: a Multicenter, Bidirectional Cohort Study
NCT06510127 ·Status: ENROLLING_BY_INVITATION
-
Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast Cancer Patients After Neoadjuvant Therapy
NCT06649565 ·Status: RECRUITING
-
Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy
NCT03381092 ·Status: UNKNOWN
-
Survival of BCS vs Mx in Asymptomatic Screen-detected NPBC
NCT06103032 ·Status: COMPLETED
-
The Diagnosis and Prognosis of Nonpalpable Breast Cancer Detected by the US vs Mammography: a Clinical Noninferiority Trial.
NCT04360616 ·Status: UNKNOWN